Engineered Akkermansia muciniphila: A promising agent against diseases (Review)
Authors:
Open Access
- 29 October 2020
- journal article
- review article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (6) , 1
Abstract
Achieving a harmonious gut microbial ecosystem has been hypothesized to be a successful method for alleviating metabolic disorders. The administration of probiotics, such as Lactobacillus and Bifidobacteria, is a known traditional and safe pathway to regulate human commensal microbes. With advancements in genetic sequencing and genetic editing tools, more bacteria are able to function as engineered probiotics with multiple therapeutic properties. As one of the next‑generation probiotic candidates, Akkermansia muciniphila (A. muciniphila) has been discovered to enhance the gut barrier function and moderate inflammatory responses, exhibit improved effects with pasteurization and display beneficial probiotic effects in individuals with obesity, type 2 diabetes, atherosclerosis and autism‑related gastrointestinal disturbances. In view of this knowledge, the present review aimed to summarize the effects of A. muciniphila in the treatment of metabolic disorders and to discuss several mature recombination systems for the genetic modification of A. muciniphila. From gaining an enhanced understanding of its genetic background, ingested A. muciniphila is expected to be used in various applications, including as a diagnostic tool, and in the site‑specific delivery of therapeutic drugs.Keywords
This publication has 133 references indexed in Scilit:
- Human Gut Microbiota Changes Reveal the Progression of Glucose IntolerancePLOS ONE, 2013
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences, 2013
- “Direct cloning in Lactobacillus plantarum: Electroporation with non-methylated plasmid DNA enhances transformation efficiency and makes shuttle vectors obsolete”Microbial Cell Factories, 2012
- Immune mechanisms of Concanavalin A model of autoimmune hepatitisWorld Journal of Gastroenterology, 2012
- Low Relative Abundances of the Mucolytic Bacterium Akkermansia muciniphila and Bifidobacterium spp. in Feces of Children with AutismApplied and Environmental Microbiology, 2011
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal MetagenomesPLOS ONE, 2011
- Genome editing with engineered zinc finger nucleasesNature Reviews Genetics, 2010
- Optimised electroporation mediated DNA vaccination for treatment of prostate cancerGenetic Vaccines and Therapy, 2010
- Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilusJournal of Bacteriology, 2008